Phibro Animal Health CorporationPAHCNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank74
3Y CAGR+12.1%
5Y CAGR-40.8%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+12.1%/yr
Quarterly compound
5Y CAGR
-40.8%/yr
Recent acceleration
Percentile
P74
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 108.04% |
| Q3 2025 | -56.27% |
| Q2 2025 | -50.71% |
| Q1 2025 | 1302.93% |
| Q4 2024 | -75.63% |
| Q3 2024 | -55.60% |
| Q2 2024 | 149.20% |
| Q1 2024 | -63.85% |
| Q4 2023 | 94.81% |
| Q3 2023 | -19.96% |
| Q2 2023 | 223.34% |
| Q1 2023 | 351.47% |
| Q4 2022 | 76.73% |
| Q3 2022 | -779.67% |
| Q2 2022 | -74.33% |
| Q1 2022 | -69.53% |
| Q4 2021 | 426.62% |
| Q3 2021 | 24.46% |
| Q2 2021 | -81.53% |
| Q1 2021 | -38.23% |
| Q4 2020 | 1484.98% |
| Q3 2020 | -56.20% |
| Q2 2020 | -85.61% |
| Q1 2020 | -16.02% |
| Q4 2019 | 998.91% |
| Q3 2019 | -123.99% |
| Q2 2019 | -4.95% |
| Q1 2019 | 1.94% |
| Q4 2018 | 1099.69% |
| Q3 2018 | -87.34% |
| Q2 2018 | -55.67% |
| Q1 2018 | -29.37% |
| Q4 2017 | 572.29% |
| Q3 2017 | -64.68% |
| Q2 2017 | -63.32% |
| Q1 2017 | 41.10% |
| Q4 2016 | 22.47% |
| Q3 2016 | -19.31% |
| Q2 2016 | 429.51% |
| Q1 2016 | -37.21% |